NEUREN PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.25 AUD | +3.22% |
|
-0.16% | -22.91% |
| Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
| Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Chart calendar Neuren Pharmaceuticals Limited
fbfabee6fda21b1c.j4mNSTi9srQAL1HUPKHR71gvfCSG8R93MT7csTOdbuU.5cPrfV3608JRAjqDWfnjpwh3LAnNq3RAAUyqwWCqXbLX8eU4avPo8TkZMg~c49e69e620e0e3d8733d42e87f26dddd
Upcoming events on Neuren Pharmaceuticals Limited
Past events on Neuren Pharmaceuticals Limited
| 2024-04-23 08:05 pm | March 2024 Sales and Revenue Release - Activities Report |
| 2024-02-29 12:30 am | Q4 2023 Earnings Call |
| 2024-02-28 11:40 pm | Q4 2023 Earnings Release |
| 2024-01-30 09:09 pm | December 2023 Sales and Revenue Release - Activities Report |
| 2023-12-17 06:30 pm | NNZ-2591 Phase II Clinical Trial Results Call |
| 2023-10-19 06:30 pm | September 2023 Sales and Revenue Release - Activities Report |
| 2023-08-27 09:00 pm | Q2 2023 Earnings Call |
| 2023-08-27 07:28 pm | Q2 2023 Earnings Release |
| 2023-07-30 07:31 pm | June 2023 Sales and Revenue Release - Activities Report |
| 2023-07-13 07:30 pm | Business Update Call |
| 2023-06-08 02:00 pm | Jefferies Global Healthcare Conference |
| 2023-04-27 07:24 pm | March 2023 Sales and Revenue Release - Activities Report |
| 2023-03-13 06:00 pm | DAYBUE Approval Call |
| 2023-02-23 05:36 pm | FY 2022 Earnings Release |
| 2023-01-30 05:49 pm | December 2022 Sales and Revenue Release - Activities Report |
| 2022-11-16 | Jefferies London Healthcare Conference |
| 2022-10-26 06:35 pm | September 2022 Sales and Revenue Release - Activities Report |
| 2022-09-13 | ASX Small & Mid-Cap Conference |
| 2022-08-23 07:19 pm | Interim 2022 Earnings Release |
| 2022-07-28 | June 2022 Sales and Revenue Release - Activities Report |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,02 0,40 154% | 0,96 1,00 -3.6% | 3,64 1,25 190.88% | 17,0 15,7 8.55% | 232 231 0.23% | 154 |
|
EBITDA Million AUD | Released Forecast Spread | -11,1 -14,0 20.91% | -8,56 -11,7 26.87% | -7,79 -9,70 19.72% | -1,59 -6,74 76.48% | 199 197 1.35% | 119 |
|
EBIT Million AUD | Released Forecast Spread | -10,6 -14,0 24.61% | -8,56 -11,7 26.82% | -7,79 -9,70 19.64% | -1,60 -6,46 75.3% | 199 196 1.46% | 124 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -10,8 -13,7 21.05% | -9,19 -11,1 17.18% | -7,79 -9,40 17.08% | 0,18 -6,57 102.8% | 205 202 1.57% | 146 |
|
Net income Million AUD | Released Forecast Spread | -10,8 -13,7 21.05% | -9,19 -11,1 17.18% | -7,79 -9,24 15.69% | 0,18 -6,01 103.06% | 157 171 -8% | 92,5 |
|
EPS AUD | Released Forecast Spread | -0,11 -0,14 21.17% | -0,09 -0,10 16.5% | -0,07 -0,08 15.38% | 0,00 -0,05 102.13% | 1,20 1,35 -11.22% | 0,73 |
| Announcement Date | 25/02/20 | 23/02/21 | 23/02/22 | 23/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,73 0,40 83.25% | 0,55 0,00 - | 0,41 1,00 -59% | 3,40 2,50 36.08% | 0,28 0,00 - | 16,8 13,9 20.5% | 64,4 63,1 2.07% | 169 170 -0.35% | 28,8 | 163 | |
|
EBITDA Million AUD | Released Forecast Spread | -3,17 -6,00 47.2% | -4,76 -5,90 19.36% | -3,80 -6,40 40.66% | 49,6 46,0 7.89% | 151 179 -15.75% | 11,5 | 143 | ||||
|
EBIT Million AUD | Released Forecast Spread | -2,93 -6,10 51.95% | -4,76 -5,90 19.31% | -3,80 -6,40 40.61% | -5,90 0,00 - | 4,31 -3,40 226.71% | 49,6 49,3 0.65% | 151 204 -25.79% | ||||
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -2,93 -5,80 49.47% | -4,76 -5,80 17.91% | -4,43 -6,30 29.65% | 49,6 46,5 6.71% | 156 204 -23.77% | ||||||
|
Net income Million AUD | Released Forecast Spread | -2,93 -5,80 49.47% | -4,76 -5,80 17.91% | -4,43 -6,30 29.65% | -7,96 | 0,17 -2,50 106.8% | -7,05 -4,50 -56.76% | 7,24 -3,40 312.88% | 47,8 49,6 -3.52% | 109 138 -20.61% | 8,00 | 104 |
|
EPS AUD | Released Forecast Spread | 0,37 0,36 2.22% | 0,83 1,15 -27.25% | 0,51 | 0,56 | |||||||
| Announcement Date | 25/02/20 | 25/08/20 | 23/02/21 | 24/08/21 | 23/02/22 | 23/08/22 | 23/02/23 | 27/08/23 | 29/02/24 | - | - |
More events
Past sector events for Neuren Pharmaceuticals Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NEU Stock
- Calendar Neuren Pharmaceuticals Limited
